[Translation] A multicenter, randomized, double-blind, active-controlled (BOTOX®) and placebo-controlled study to evaluate the efficacy and safety of QM1114-DP in Chinese subjects with moderate to severe glabellar lines
本研究的主要目的是验证50U QM1114-DP治疗中度至重度GL相对于安慰剂的优效性。如果得到验证,将评价单次给予50U QM1114-DP与20UA型肉毒毒素治疗中度至重度GL的非劣效性。
[Translation] The primary objective of this study was to verify the superiority of 50U QM1114-DP in the treatment of moderate to severe GL over placebo. If validated, the non-inferiority of a single administration of 50U of QM1114-DP versus 20UA of botulinum toxin in the treatment of moderate-to-severe GL will be evaluated.